171
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Facile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm control

, , , , , , & show all
Pages 2155-2171 | Published online: 18 Mar 2015

References

  • MagillSSEdwardsJRBambergWMultistate point-prevalence survey of health care-associated infectionsN Engl J Med20143701198120824670166
  • GristinaAGImplant failure and the immuno-incompetent fibro-inflammatory zoneClin Orthop Relat Res19942981061188118964
  • MunfordRSSevere sepsis and septic shock: the role of gram-negative bacteremiaAnnu Rev Pathol2006146749618039123
  • HetrickEMSchoenfischMHReducing implant-related infections: active release strategiesChem Soc Rev200635978078916936926
  • GuerreroGAmalricJMutinPHSottoALavigneJPInhibition of bacterial adhesion and prevention of biofilm formation: use of organic self-assembled monolayers on inorganic surfacesPathol Biol (Paris)200957364318824310
  • DefezCFabbro-PerayPCazabanMBoudemagheTSottoADauresJPAdditional direct medical costs of nosocomial infections: estimation from a cohort of patients in a French university hospitalJ Hosp Infect20086813013618201796
  • MeiLLuZZhangWBioconjugated nanoparticles for attachment and penetration into pathogenic bacteriaBiomaterials20133438103281033724090838
  • LaraHHGarza-TreviñoENIxtepan-TurrentLSinghDKSilver nanoparticles are broad-spectrum bactericidal and virucidal compoundsJ Nanobiotechnol2011930
  • VeerapandianMYunKFunctionalization of biomolecules on nanoparticles: specialized for antibacterial applicationsAppl Microbiol Biotechnol20119051655166721523475
  • ErnestVGajalakshmiSMukherjeeAChandrasekaranNEnhanced activity of lysozyme-AgNP conjugate with synergic antibacterial effect without damaging the catalytic site of lysozymeArtif Cells Nanomed Biotechnol201442533634323863117
  • BrownANSmithKSamuelsTALuJObareSOScottMENanopar-ticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureusAppl Environ Microbiol20127882768277422286985
  • LiuLHXuKJWangHYSelf assembled cationic peptide nano-particles as an efficient antimicrobial agentNat Nanotechnol2009445746319581900
  • WangHXuKLiuLThe efficacy of self assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitisBiomaterials2010312874288120044131
  • HancockRESahlHGAntimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNat Biotechnol2006241551155717160061
  • PettyJTZhengJHudNVDicksonRMDNA-templated Ag nanocluster formationJ Am Chem Soc20041265207521215099104
  • JonesMROsbergKDMacfarlaneRJLangilleMRMirkinCATemplated techniques for the synthesis and assembly of plasmonic nanostructuresChem Rev20111113736382721648955
  • MorrisonDCJacobsDMBinding of polymyxin B to the lipid A portion of bacterial lipopolysaccharidesImmunochemistry197613813818187544
  • SergeevBMKiryukhinMVRubtsovaMYPrusovANSynthesis of protein A conjugates with silver nanoparticlesColl J200365636638
  • SoonhyangPHichamCJodyWNadeauJLAntimicrobial activity and cellular toxicity of nanoparticle–polymyxin B conjugatesNanotechnology20112218510121415471
  • MunroCHSmithWEGarnerMClarksonJWhitePCCharacterization of the surface of a citrate-reduced colloid optimized for use as a substrate for surface-enhanced resonance Raman-scatteringLangmuir19951137123720
  • Clinical and Laboratory Standards InstituteMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard8th edM07-A8Wayne, PACLSI2009
  • GhoshINPatilSDSharmaTKSrivastavaSKPathaniaRNavaniNKSynergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applicationsInt J Nanomedicine201384721473124376352
  • RudenSHilpertKBerditschMWadhwaniPUlrichASSynergistic interaction between silver nanoparticles and membrane permeabilizing antimicrobial peptidesAntimicrob Agents Chemo20095335383540
  • BendaoudMVinogradovEBalashovaNVKadouriDEKachlanySCKaplanJBBroad-spectrum biofilm inhibition by Kingella kingae exopolysaccharideJ Bacteriol2011153879388621602333
  • InbakandanDKumarCAbrahamLSKirubagaranRVenkatesanRKhanSASilver nanoparticles with anti microfouling effect: a study against marine biofilm forming bacteriaColloids Surf B Biointerfaces201311163664323907051
  • O’TooleGAMicrotiter dish biofilm formation assayJ Vis Exp201147e2437
  • O’TooleGAPrattLAWatnickPINewmanDKWeaverVBKolterRGenetic approaches to study of biofilmsMethods Enzymol1999319110910547784
  • BarraudNBusonAJarolimekWRiceSAMannitol enhances antibiotic sensitivity of persister bacteria in P. aeruginosa biofilmsPLoS One2013812e8422024349568
  • StoodleyHLCostertonJWStoodleyPBacterial biofilms: from the natural environment to infectious diseasesNat Rev Microbiol200429510815040259
  • RadzigMANadtochenkoVAKoksharovaOAKiwiJLipasovaVAKhmelIAAntibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of actionColloids Surf B Biointerfaces201310230030623006569
  • EbyDMLuckariftHRJohnsonGRHybrid antimicrobial enzyme and silver nanoparticle coatings for medical instrumentsAppl Mater Interfaces2009115531560
  • MockJJBarbicMSmithDRSchultzDASchultzSShape effects in plasmon resonance of individual colloidal silver nanoparticlesJ Chem Phys200211667556759
  • DhawanASharmaVToxicity assessment of nanomaterials: methods and challengesAnal Bioanal Chem201039858960520652549
  • SocratesGInfrared and Raman Characteristic Group Frequencies, Tables and ChartsChichester, UKJohn Wiley and Sons Ltd20013
  • FormaggioFCrismaMRossiPThe first water-soluble 310-helical peptidesChem Eur J200064498450411192082
  • TonioloCPoleseAFormaggioFKamphuisCMCircular dichroism spectrum of a peptide 310-helixJ Am Chem Soc19961827442745
  • PathaniaRZlitniSBarkerCChemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targetingNat Chem Biol20091184985619783991
  • DaugelaviciusRBakieneEBamfordDHStages of polymyxin B interaction with the Escherichia coli cell envelopeAntimicrob Agents Chemother200044112969297811036008
  • BondarenkoOIvaskAKakinenAKurvetIKahruAParticle-cell contact enhances antibacterial activity of silver nanoparticlesPLoS One20138e6406023737965
  • SauerKCamperAKEhrlichGDCostertonJWDaviesDGPseudomonas aeruginosa displays multiple phenotypes during development as a biofilmJ Bacteriol200218441140115411807075
  • PalmerJFlintSBrooksJBacterial cell attachment, the beginning of a biofilmJ Ind Microbiol Biotechnol20073457758817619090
  • MichaelBFrederikHFranziskaBWeilenmannHUEgliTAssessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometryAppl Environ Microbiol2007733283329017384309
  • GiãoMSWilksSAAzevedoNFVieiraMJKeevilCWValidation of SYTO 9/propidium iodide uptake for rapid detection of viable but non-cultivable Legionella pneumophilaMicrob Ecol200958566219043657
  • HéquetAHumblotVBerjeaudJMPradierCMOptimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance testsColloids Surf B Biointerfaces201184230130921310597
  • VincentJLLaterrePFCohenJA pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infectionShock200523540040515834304
  • DaviesBCohenJEndotoxin removal devices for the treatment of sepsis and septic shockLancet Infect Dis201111657121183148